Abstract
Microbial metabolites identified in animal models and human neurological diseases could be therapeutic targets.
MeSH terms
-
Animals
-
Autism Spectrum Disorder* / therapy
-
Brain* / physiopathology
-
Brain-Gut Axis*
-
Disease Models, Animal
-
Dystonia* / therapy
-
Gastrointestinal Microbiome*
-
Host Microbial Interactions*
-
Humans
-
Intellectual Disability* / therapy
-
Mice
-
Nystagmus, Congenital* / therapy
-
Spastic Paraplegia, Hereditary* / therapy
Supplementary concepts
-
Amyotrophic Dystonic Paraplegia